基于网络药理学和分子对接研究车前子-赤芍对治疗青光眼的作用机制

doi:10.3969/j.issn.1001-8131.2024.02.001

Abstract
Figure/Table
References
Related Citation (4)

Download: PDF (1615 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the mechanism of plantagus-red Peony root in the treatment of glaucoma by network pharmacology and molecular docking technology. Methods The active ingredient targets of Plantagina plantagina and red Peony root and glaucoma related targets were collected through TCMSP,Gene Cards and other databases.The STRING database and Cytoscape software were used to construct the protein interaction network diagram,and the visual network diagram of drug-active ingredient-target-disease was drawn.The DAVID database was used for GO functional enrichment analysis and KEGG pathway enrichment analysis.PyMolWin software was used for molecular docking. Results A total of 75 intersection targets between drug pair and glaucoma disease were obtained.The core targets were AKT1,CASP3 and TP53.GO functional enrichment analysis obtained 232 information,and KEGG pathway enrichment analysis identified 207 related pathways.Molecular docking results showed that the key targets were in stable conformation with the active ingredients of the drug. Conclusion The Plantagina Rpeony drug pair may act on AKT1,CASP3,TP53 and other targets,through PI3K-Akt signaling pathway,neurotrophic factor signaling pathway and other related pathways,thereby regulating intraocular pressure and protecting the optic nerve.

Key words： Psyllium-Red Peony pair Glaucoma Network pharmacology Molecular docking

Received: 25 January 2024

PACS:

R775.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Lu Hai
	Xiang Chenyue
	Ma Yiping

Cite this article:

Lu Hai,Xiang Chenyue,Ma Yiping. The Mechanism of Psyllium-red Peony Root in the Treatment of Glaucoma Was Studied Based on Network Pharmacology and Molecular Docking[J]. journal1, 2024, 44(2): 1-4.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2024.02.001 OR http://www.hrbyybjb.org.cn/EN/Y2024/V44/I2/1

[1] 李银鑫,欧晨,周亚莎,等.彭清华教授采用青光安Ⅱ号方治疗青光眼中晚期视神经损害[J].亚太传统医药,2020,16(12):113-116.
[2] 中华医学会眼科学分会青光眼学组,中国医师协会眼科医师分会青光眼学组.中国青光眼指南(2020年)[J].中华眼科杂志,2020,56(8):573-586.
[3] 谢辉,易文.用中医特色疗法治疗视神经萎缩的研究进展[J].当代医药论丛,2022,20(7):50-52.
[4] Kong LY,Tang RX.Artemisinin,a miracle of traditional Chinese medicine[J].Nat Prod Rep,2015;32(12):1617-1621.
[5] 王金言,郝德国,徐乐乐,等.基于网络药理学和分子对接探究苍耳子治疗鼻炎的作用机制[J].沈阳药科大学学报,2022,39(7):798-805,811.
[6] 雷蕾,杨策,温先荣,等.基于复杂网络的心绞痛血瘀证中药组方研究[J].世界中医药,2013,(9):1101-1104.
[7] 刘洋. 雷公藤治疗口腔鳞状细胞癌的网络药理学分析和分子对接研究[D].山西医科大学,2021.
[8] 赵苗青,李丰,石彬彬,等.系统药理学(Ⅵ)——TCMSP数据库及其应用[J].中医药信息,2020,37(3):22-29.
[9] 徐硕,徐文峰,梁晓丽,等.车前子的化学成分及生物活性研究进展[J].西北药学杂志,2019,4(4):567-568,封3-封4.
[10] 陆小华,马骁,王建,等.赤芍的化学成分和药理作用研究进展[J].中草药,2015,46(4):595-602.
[11] 费静,郑红弟,余莉亚,等.胶质细胞源性神经营养因子/PI3K/AKT通路参与电针促进面神经压榨损伤模型兔的面神经再生[J].中国组织工程研究,2020,24(7):1094-1100.
[12] 李想,李安特,孙秋霞,等.PI3K/Akt信号通路与神经损伤修复的研究进展[J].中国老年学杂志,2023,43(1):246-249.
[13] Neven,Hassan,Maha,et al.alleviates hepatic and renal mitochondrial-dependent apoptotic progression induced by letrozole in female rats through modulation of Nrf-2,Cyt c and CASP signaling[J].Drug and chemical toxicology,2023,46(2):357-368.
[14] 张静晓,刘晓洁,杨春,等.几种天然产物与CASP3靶点的相互作用机制探索[J].世界科学技术-中医药现代化,2017,19(11):1824-1828.
[15] 万宇,李战梅,黄海,等.润燥明目汤对急性高眼压大鼠视网膜及其组织Caspase-3 Bcl-2 Bax表达的影响[J].实验动物与比较医学,2020,40(1):53-59.